These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6610110)

  • 1. Parathyroid hormone measurements in hemodialysis patients as assessments of renal osteodystrophy.
    Aubry WM; Sparks JC; Braunstein GD
    Mt Sinai J Med; 1984 Apr; 51(2):132-7. PubMed ID: 6610110
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal osteodystrophy in children on maintenance haemodialysis.
    Mehls O; Krempien B; Ritz E; Schärer K; Schüler HW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):197-201. PubMed ID: 4802577
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
    Fournier A; Ghitu S; Bako G; Ben Amar L; Oprisiu R; Hottelart C; Cohen Solal ME
    Nephrol Dial Transplant; 1999 Nov; 14(11):2772-4. PubMed ID: 10534531
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on calcium-regulating hormone in patients on chronic hemodialysis with special reference to renal osteodystrophy (ROD) (author's transl)].
    Kudo S
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):181-96. PubMed ID: 7098141
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal markers of early-stage osteitis fibrosa in patients on hemodialysis].
    Persichetti S; Sagliaschi G; Clemenzia G; Angelitti A; Gallo G; Maggi S; Ponzio R; Punzo G; Tozzo C
    Minerva Med; 1992 Nov; 83(11):721-4. PubMed ID: 1461543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E
    J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal osteodystrophy].
    Schober HC
    Z Urol Nephrol; 1986 Oct; 79(10):595-602. PubMed ID: 3811647
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of bloodless methods in the study of renal osteodystrophy: comparison with bone histomorphometry].
    González-Posada JM; Torres A; Lorenzo V; Losada M; Maceira B; Hernández Nieto L; Díaz-Flores L
    Med Clin (Barc); 1987 Feb; 88(7):268-73. PubMed ID: 3561071
    [No Abstract]   [Full Text] [Related]  

  • 9. The need for reliable serum parathyroid hormone measurements.
    Torres PU
    Kidney Int; 2006 Jul; 70(2):240-3. PubMed ID: 16838038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of renal osteodystrophy following renal transplantation.
    Pierides AM; Ellis HA; Peart KM; Simpson W; Uldall PR; Kerr DN
    Proc Eur Dial Transplant Assoc; 1975; 11():481-7. PubMed ID: 1105559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal osteodystrophy].
    Servodio Iammarrone C; Di Cicco N; Di Salle F
    Chir Organi Mov; 1987; 72(2):125-36. PubMed ID: 3677868
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations.
    Meany DL; Jan de Beur SM; Bill MJ; Sokoll LJ
    Clin Chem; 2009 Sep; 55(9):1737-9. PubMed ID: 19717659
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of Liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients.
    Cavalier E; Delanaye P; Krzesinski JM; Chapelle JP
    Clin Chem Lab Med; 2005; 43(8):890-1. PubMed ID: 16201903
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renal osteodystrophy in patients on maintenance hemodialysis: statistical study of clinical, radiological and biochemical features].
    Zwahlen A; Leski M; Burckhardt P; Assimacopoulos A; Garcia J; Szary L; Courvoisier B
    Schweiz Med Wochenschr; 1981 Jan; 111(5):154-6. PubMed ID: 7280647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of assays for parathyroid hormone.
    Goodman WG
    Semin Dial; 2005; 18(4):296-301. PubMed ID: 16076352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum procollagen type I carboxyterminal propeptide in CAPD and hemodialysis patients.
    Gerakis A; Apostolou T; Bagiatoudi G; Tzouganatou A; Margellos V; Nikolopoulou N; Billis A
    Perit Dial Int; 1996; 16 Suppl 1():S309-11. PubMed ID: 8728213
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of intact parathyroid hormone in samples from hemodialysis patients.
    Cavalier E; Delanaye P; Carlisi A; Krzesinski JM; Chapelle JP
    Kidney Int; 2007 Aug; 72(3):370-2. PubMed ID: 17554256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed.
    Ferreira MA
    Nephrol Dial Transplant; 2000; 15 Suppl 5():8-14. PubMed ID: 11073268
    [No Abstract]   [Full Text] [Related]  

  • 20. Target levels for serum phosphorus and parathyroid hormone.
    Qunibi W; Kalantar-Zadeh K
    Semin Dial; 2011; 24(1):29-33. PubMed ID: 21324001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.